Elevance Health 2026年季度报告

(Mark One) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2026OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934 220 Virginia AvenueIndianapolis, Indiana 46204(Address of principal executive offices) (Zip Code) Name of each exchange on which registered New York Stock Exchange Indicate by check mark whether the registrant: (1)has filed all reports required to be filed by Section13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),and (2)has been subject to such filing requirements for the past90days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that theregistrant was required to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smallerreporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act: Large accelerated filerNon-accelerated filerEmerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)Yes☐No☒As of July 10, 2026, 216,869,290 shares of the Registrant’s Common Stock were outstanding. Elevance Health, Inc.Quarterly Report on Form 10-QFor the Period Ended June30, 2026Table of Contents PART I. FINANCIAL INFORMATION ITEM1.FINANCIAL STATEMENTSConsolidated Balance Sheets as ofJune30, 2026(Unaudited) and December31, 20252Consolidated Statements of Income (Unaudited) for theThree and Six Months Ended June 30, 2026and20253Consolidated Statements of Comprehensive Income (Unaudited) for the Three andSix Months Ended June 30,2026and20254Consolidated Statements of Cash Flows (Unaudited) for theSix Months Ended June 30, 2026and20255Consolidated Statements of Changes in Total Equity (Unaudited) for theSix Months Ended June 30, 2026and20256Notes to Consolidated Financial Statements (Unaudited)8ITEM2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OFOPERATIONS35ITEM3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK53ITEM4.CONTROLS AND PROCEDURES53PART II. OTHER INFORMATIONITEM1.LEGAL PROCEEDINGS53ITEM1A.RISK FACTORS53ITEM2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS54ITEM3.DEFAULTS UPON SENIOR SECURITIES54ITEM4.MINE SAFETY DISCLOSURES54ITEM5.OTHER INFORMATION54ITEM6.EXHIBITS55SIGNATURES56 Elevance Health, Inc.Consolidated Statements of Comprehensive Income(Unaudited) Elevance Health, Inc.Notes to Consolidated Financial Statements(Unaudited)June30, 2026 (In Millions, Except Per Share Data or As Otherwise Stated Herein) 1.Organization References to the terms “we,” “our,” “us” or “Elevance Health” used throughout these Notes to Consolidated Financial Statementsrefer to Elevance Health, Inc., an Indiana corporation, and unless the context otherwise requires, its direct and indirect subsidiaries.References to the “states” include the District of Columbia and Puerto Rico unless the context otherwise requires. Elevance Health is a health company with the purpose of improving the health of humanity. We are one of the largest healthinsurers in the United States in terms of medical membership, serving approximately 44.9 million medical members through ouraffiliated health plans as of June30, 2026. We offer a broad spectrum of network-based managed care risk-based plans to Individual,Employer Group, Medicaid and Medicare markets. In addition, we provide a broad array of managed care services to fee-basedcustomers, including claims processing, stop loss insurance, care provider network access, medical management, care management,wellness programs, actuarial services and other administrative services. Across these markets, we generate revenue through risk-basedpremiums, administrative fees from self-funded employers and pharmacy and health service fees through our Carelon businesses. Weprovide services to the federal government in connection with our Federal Health Products & Services business, which administers theFederal Employee Program(“FEP ”). We provide an array of specialty services both to customers of our subsidiary health plans andto unaffiliated health plans, including pharmacy services, stop loss insurance, dental, vision and supplemental he